Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
-
- Takahisa Nakamura
- editor
収録刊行物
-
- PLOS ONE
-
PLOS ONE 11 (3), e0151511-, 2016-03-15
Public Library of Science (PLoS)